The Leadership Team at IMMvention Therapeutix is responsible for guiding the company's strategic direction, overseeing research and development initiatives, and ensuring financial sustainability. Composed of the CEO, VPs of R&D and Finance, and Scientific Founders, this team collaborates to drive innovative therapy development aimed at addressing diseases linked to excessive cytokine production through inflammasome inhibition. Their collective expertise fuels the company's mission to translate scientific breakthroughs into effective therapeutic solutions.
View all